Dr. Sheinkop had over 37 years of experience in joint replacement surgery before moving into the field of regenerative medicine, according to a Feb. 16 press release.
QC Kinetix utilizes regenerative medicine treatments to allow the body to treat itself, so patients can avoid surgery for musculoskeletal discomfort.
In his position, Dr. Sheinkop will head the medical management team, focusing on the evaluation and enhancement of protocols, as well as spearheading research and development initiatives. Additionally, he will focus on refining the training and certification processes for practitioners.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.